TNF and cancer: Major inflammatory stimuli in the tumor microenvironment such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and toll-like receptor (TLR) ligands released from dying cells during cancer treatment activate NF-κB in surviving cancer cells [9,10,11].